Provided by Tiger Fintech (Singapore) Pte. Ltd.

Entrada Therapeutics, Inc.

6.55
-0.2100-3.11%
Post-market: 6.53-0.0200-0.31%18:39 EDT
Volume:220.02K
Turnover:1.45M
Market Cap:248.59M
PE:10.80
High:6.84
Open:6.75
Low:6.48
Close:6.76
Loading ...
Aug 11, 2022

Major Issues Report

8-K - Current report
Aug 11, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 03, 2022

Major Issues Report

8-K - Current report
May 12, 2022

Major Issues Report

8-K - Current report
May 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 22, 2022

Major Issues Report

8-K - Current report
Mar 15, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 15, 2022

Major Issues Report

8-K - Current report
Mar 15, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 16, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Dec 09, 2021

Major Issues Report

8-K - Current report
Dec 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Nov 12, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Nov 10, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 02, 2021

Major Issues Report

8-K - Current report